Diagnosis
Adrenal insufficiency
Primary: Destruction of adrenal cortex
Secondary: Failure due to hypothalamic or pituitary abnormalities
Addisonian Crisis: Acute situation due to some extrinsic stressor such as infection, surgery or sudden cessation of long-term glucocorticoid therapy
Also known as: Addison's disease, Autoimmune adrenalitis, Primary adrenal insufficiency
Etiology
Primary adrenal insufficiency [moh]
Infections leading to adrenalitis: Tuberculosis, HIV, CMV, Cryptococcosis, Histoplasmosis, Coccidiomycosis, Candidiasis, African trypanomiasis, Treponema pallidum
Bilateral adrenal hemorrhage: Septic shock (Waterhouse-Friderichsen syndrome), Anticoagulants, Trauma
Adrenal infarction: Primary antiphospholipid syndrome, Anti-cardiolipin syndrome, Lupus anti-coagulant syndrome
Adrenal infiltration: Autoimmune (Addison’s Disease), Adrenal metastases, Primary adrenal lymphoma, Sarcoidosis, Amyloidosis, Hemochromatosis
Bilateral adrenalectomy: Cushing's disease, ectopic ACTH, renal cancer, pheochromocytoma
Drug-induced adrenal insufficiency: side-effect due to steroid synthesis inhibition, GC antagonist or increased cortisol metabolism
Mifepristone, Abiraterone acetate, Trilostane, Etomidate, Ketaconazole/fluconazole, Suramin, Aminoglutethiamide, Phenytoin, Phenobarbital, Rifampicin, CTLA-4 inhibitors
Secondary adrenal insufficiency
Iatrogenic: Exogenous steroid treatment (adrenal suppression), hypersecretion due to Cushing's syndrome, Following TSS surgery for ACTH producing adenoma, Pituitary irradiation and radiotherapy for brain tumors and craniospinal irradiation for other tumors
Tumors: Pituitary adenoma (rarely carcinoma), Craniopharyngioma, meningioma, ependymoma, intra/suprasellar metastasis
Infiltration/deposition: Tuberculosis, actinomycosis, sarcoidosis, histiocytosis X, Wegener’s granulomatosis, Hemochromatosis
Autoimmune: Autoimmune hypophysitis (pregnancy)
Infarction/hemorrahage: Pituitary apoplexy/necrosis, Postpartum pituitary infarction (Sheehan's syndrome)
Trauma: Pituitary stalk lesions, Traumatic brain injury
Genetic causes: Familial Glucocorticoid deficiency, Cholesteryl ester storage disease, Smih-Lemi Opitz disease, Kearns–Sayre syndrome, Refsum disease, Congenital adrenal hypoplasia, IMAGe syndrome, MIRAGE syndrome, Combined pituitary hormone deficiency.
Pathophysiology [sau]
Destruction of the bilateral adrenal cortex
Decreased adrenocortical hormones (cortisol, aldosterone, and androgens)
Epidemiology
Incidence per 100.000 [uak][fkw][ygg][sau]
Prevalence per 100.000 [uak][fkw][ygg][sau]
Symptoms & findings
Symptoms
Amenorrhea, Arthralgia, Confusion, Dizziness, Fatigue, Fever, Hyperpigmentation, Hypotension, Lethargy, Myalgia, Nausea, Tachycardia, Vomiting, Weakness, Weight loss
Clinical findings
Decreased Cortisol, Hyperkalemia, Hyponatremia, Shock
Anamneses
None listed.
Localized findings
Approach
ACTH stimulation test
Comprehensive metabolic panel (TSH, Prolactin)
Complete blood cell (CBC) count
Autoantibody testing: Thyroid and/or adrenal autoantibodies may be present
Chest radiograph
Abdominal CT
Treatment
Acute adrenal crisis: [sau]
NaCl i.v. to restore volume deficit and correct hypotension
Dextrose: to correct hypoglycemia
Correction of the hormone deficiency: both glucocorticoid and mineralocorticoid
Hydrocortisone 100 mg intravenous (IV) bolus
Followed by 50 to 100 mg IV every 6 hours over 24 hours
Maintenance Phase Therapy:
Glucocorticoid
Hydrocortisone 5 to 25 mg/day divided into 2 or 3 doses
Prednisone 3 to 5 mg/day
Mineralocorticoid
Fludrocortisone 0.05 to 0.2 mg daily
Hydrocortisone (in children) 8 mg/m2/day orally initially, divided into 3 or 4 doses
Differential diagnoses
Fibromyalgia, Histoplasmosis, Hyperkalemia, Hypothyroidism, Hypovolemia, Mononucleosis, Sarcoidosis, Sepsis, Shock, Syndrome of inappropriate antidiuretic hormone secretion, Tuberculosis
References
[1] Hasenmajer V, Ferrigno R, Minnetti M, Pellegrini B, Isidori AM, Lenzi A, Salerno M, Cappa M, Chan L, De Martino MC, Savage MO. Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia. Rev Endocr Metab Disord. 2023 Apr;24(2):345-363.
[2] Munir et al. Addison Disease. 2024 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 28723023.
[3] Løvås K, Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol (Oxf). 2002 Jun;56(6):787-91.
[4] https://emedicine.medscape.com/article/116467-overview?form=fpf#a6
[5] https://emedicine.medscape.com/article/1096911-overview?form=fpf#a6